Saballa, Shiela .

HRN: 03-63-43  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/13/2025
07/19/2025
IV
500mg
Q6
AGE
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueIntra-abdominal    Compliance to guidelines: Compliant To Guidelines